help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 10, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0964
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
92/1/137    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nimkarn, S.
Right arrow Articles by New, M. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nimkarn, S.
Right arrow Articles by New, M. I.

Submitted on May 5, 2006
Accepted on October 3, 2006

Aldosterone-to-Renin Ratio as a Marker for Disease Severity in 21-Hydroxylase Deficiency Congenital Adrenal Hyperplasia

Saroj Nimkarn, Karen Lin-Su, Niklas Berglind, Robert C. Wilson, and Maria I. New*

Department of Pediatrics, Adrenal Steroid Disorders Program, Mount Sinai School of Medicine, New York, NY 10029; Department of Community and Preventive Medicine, Mount Sinai School of Medicine, New York, NY 10029

* To whom correspondence should be addressed. E-mail: maria.new{at}mssm.edu.

Context: Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency (21 OHD CAH) is classified clinically in decreasing order of severity into salt-wasting, simple-virilizing and nonclassical forms. Causative mutations in the CYP21A2 gene dictate the degrees of adrenal enzyme defect. Salt-wasting crises due to aldosterone deficiency are clinically apparent in the salt-wasting (SW) form, but not in other forms of 21OHD. Objectives: This study examines the ratio of serum aldosterone to plasma renin activity as an index of sodium wasting in patients with 21 OHD CAH, heterozygotes and normal individuals. Design: Cross sectional retrospective study, non interventional. Patients and other participants: A total of 402 individuals were included: 224 patients affected with 21 OHD CAH, and 178 unaffected subjects. Classification into each diagnostic group was made primarily on the basis of clinical and hormonal features. Affected or unaffected status was confirmed by genotype of CYP21A2. All subjects were on ad lib diets without restrictions. Salt-wasting status was examined by sodium deprivation testing in 32 salt-wasting subjects and 14 simple virilizing subjects. Results: The ratio of serum aldosterone to plasma renin activity was found to discriminate well between the different groups of disease severity. The lowest ratios, indicative of the least sodium conservation, were seen in the salt-wasting group with increasing ratios in the simple virilizing, nonclassical and unaffected groups. This ratio remained stable with age. Conclusion: The ratio of serum aldosterone to plasma renin activity provides a simple index to compare groups of patients with varying degrees of 21 OHD.


Key words: Salt-wasting • 21-hydroxlyase deficiency • aldosterone-to-renin ratio • congenital adrenal hyperplasia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society